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Introduction {#s1}
============

Tuberculosis (TB) continues to be a major public health problem and is currently the second largest infectious cause of death worldwide. [@pone.0109563-World1] As per World Health Organization's (WHO) estimate, in 2012, approximately 8.6 million people developed TB and 1.3 million died from it. [@pone.0109563-World1] About 58% of these new infections were reported from Asian countries, with India being the largest contributor of incident TB infections in the world (176 per 100,000 population), accounting for 26% of the total global cases in 2012. [@pone.0109563-World1].

WHO-assisted Directly Observed Treatment-Short course (DOTS) program in India not only serves more than 100,000 patients per month but also holds the distinction of being the largest and fastest expanding TB control program in the world.[@pone.0109563-World2]--[@pone.0109563-Khatri1] However, despite the significant strides made by this program, annual incidence of TB in this country still hovers above two million cases, and on an average, two TB-related deaths are reckoned to occur in every three minutes. [@pone.0109563-Tuberculosis1], [@pone.0109563-Khatri1].

Since the anti-tubercular drugs (ATD) have become available, improper regimen, indiscriminate usage and less than optimal adherence have undermined the potential benefits - largely by facilitating the emergence of drug-resistant strains, particularly the multi-drug resistant (MDR) variety. [@pone.0109563-Sharma1], [@pone.0109563-Chowdhury1] MDR-TB strains are distinguished by their resistance to isoniazid (INH) and rifampicin (RIF), two most potent first line ATDs, but not necessarily to other ATDs. [@pone.0109563-Patel1] Globally, an estimated 3.6% of new (450,000) and 20.2% of previously-treated TB cases were diagnosed with MDR-TB in 2012. [@pone.0109563-World1] Expectedly, patients with prior exposure to anti-TB therapy turned out to be the ones more vulnerable to developing drug resistance, [@pone.0109563-Faustini1] but it was perturbing to note that even the newly diagnosed cases had considerable propensity of having MDR, with possible contributing factors being spontaneous mutation and transmission of resistant strains from others patients harboring MDR-TB. [@pone.0109563-Paramasivan1], [@pone.0109563-Snider1].

Rapid emergence of drug resistance, particularly MDR constitutes a major threat to TB control in India. [@pone.0109563-Chowdhury1], [@pone.0109563-Ahuja1], [@pone.0109563-DellaLatta1] Data on drug resistance pattern prevailing in the community are scarcely available, and there exists considerable inconsistency among the published findings. [@pone.0109563-Sharma1], [@pone.0109563-Paramasivan1], [@pone.0109563-Maurya1] A 2012 country-level estimate by WHO reported India's burden of MDR-TB to be moderately high (about 2.2% of new TB cases and 15% of retreatment cases), [@pone.0109563-World1] however, there was substantial heterogeneity across reviewed studies.

The impact of MDR-TB, in terms of disease containment efforts and economic burden, on the public health infrastructure of a developing nation like India is enormous. Some of the public health challenges associated with it are: expensive laboratory procedures for diagnosis, limited number and capacity of testing facilities, long duration of treatment regime, requirement of multiple expensive, less potent, more toxic and relatively less available second line anti-TB drugs, shortage of trained staff and facilities for treatment and proper monitoring of the infected. [@pone.0109563-World1], [@pone.0109563-Ahuja1], [@pone.0109563-DellaLatta1].

The above shortcomings accompanying MDR-TB program become more glaring while addressing the problem of pulmonary TB (PTB) cases, owing to associated clinical severity. Constraints associated with the diagnosis and treatment of MDR-PTB thus call for efforts to identify the socio-demographic and clinical correlates of drug resistant PTB and poorer treatment outcomes. It is vital to take into consideration such predictors, especially the less resource intensive ones, in order to design and implement effective intervention strategies for minimizing the potential of emergence of resistant cases and improving treatment outcomes (e.g. reduction in number of relapses, defaulters and treatment-failures). In view of the above, a cross-sectional study was conducted to understand the interrelationship between diagnostic features (radiological and microscopic), patient type and drug resistance patterns among PTB patients.

Methodology {#s2}
===========

Ethics Statement {#s2a}
----------------

The Institutional Ethics Committee of the Institute of Post-Graduate Medical Education and Research (IPGMER), Kolkata, India approved the study content and procedures.

Written informed consents were collected from each participant before the interview and sample collection. Subjects were free to decline participation without any consequences towards their treatments.

Recruitment {#s2b}
-----------

Current study was conducted in the out and in-patient departments of Chest Medicine in two tertiary care hospitals (the DOTS clinic of SSKM Hospital and Chest clinic of Calcutta National Medical College) of Kolkata, a populous city of eastern India. Consenting sputum-smear-positive PTB patients (according WHO criteria and standard guidelines), [@pone.0109563-World1], [@pone.0109563-Leitch1] were recruited for the study during their first attendance between April 2010 and March 2013. Subjects were excluded from the analyses if they later turned out to be culture-negative for Mycobacterium, had infection with Mycobacterium other than *M. tuberculosis* or respective cultures got contaminated. As the parameter values regarding the variables of interest were not available in the study area, prior calculation of the required sample size was not possible. Hence we decided to recruit all the eligible cases identified during the study period.

Data Collection {#s2c}
---------------

Socio-demographic information such as age (\<20/20--45/\>45 years), gender (male/female), marital status (unmarried/married), socio-economic status (high/middle/low income group determined based on per capita monthly income, education and occupation of the head of the household using Kuppuswamy's Socio-Economic Status Scale) and district of residence (Kolkata/24 Parganas South/North) were collected through face-to-face interviews, whereas body mass index (Body weight(kg)/Height^2^(mt)) and blood hemoglobin (gm/dl) levels were measured by trained medical/paramedical staff. Based on the clinical history of diagnosis and prior treatment outcomes (if any), recruited PTB cases were classified (patient types) into new/relapse/defaulter/treatment failure according to WHO criteria. [@pone.0109563-World1].

Chest X-ray and Sputum-smear Examination {#s2d}
----------------------------------------

Chest radiographic results of the participants, as evaluated by clinicians, were categorized into minimal/moderately advanced/far advanced/having cavities. [@pone.0109563-Leitch1], [@pone.0109563-Chakraborty1] As per the WHO and Government of India collaborative guidelines, grade of sputum-smear positivity was classified into scanty/single/double/triple positive status based on microscopic findings. [@pone.0109563-Weyer1].

Laboratory testing {#s2e}
------------------

Morning sputum samples were collected from each patient and processed by digestion and decontamination using the *N*-acetyl-L-cysteine (NALC)/sodium hydroxide (NaOH) method. [@pone.0109563-Chowdhury1] The resuspended sediment from the decontaminated pellet was then used for Ziehl-Neelsen (ZN) staining, inoculation on Lowenstein-Jensen (LJ) solid and Middlebrook 7H9 liquid media. [@pone.0109563-Chowdhury1], [@pone.0109563-Kent1].

Biochemical tests (niacin test, catalase test, nitrate reduction and aryl sulfatase) were next performed to identify *M. tuberculosis* among the Mycobacterial isolates. [@pone.0109563-DellaLatta1] The positive cultures were also subjected to extraction of genomic DNA following the phenol-chloroform method. [@pone.0109563-Hosek1] Molecular confirmation was carried out by multiplex-PCR [@pone.0109563-Bhattacharya1] for amplification of hsp *65, dnaj, is6110* genes specific to *M. tuberculosis*.

Detection of drug resistance pattern {#s2f}
------------------------------------

For rapid detection of MDR isolates, multiple-allele-specific PCR (MAS-PCR) was conducted using allele-specific primers. [@pone.0109563-Yang1] For detection of Isoniazid (INH), Rifampicin (RIF) or Ethambutol (EMB) resistance, amplifications of *katG* gene and promoter region of mabA-inhA, *rpoB* gene, *embB* gene were carried out, respectively. The amplified products were visualized in a 2.5% metaphor gel under a UV GEL DOC (BIO-RAD). Based on the results, participating TB cases were classified into those infected with MDR/Non-MDR two drug/Single drug resistant or susceptible strains of *M. tuberculosis*.

All the radiological (chest X-ray) and laboratory investigation results (sputum smear examination, MAS-PCR and biochemical tests) were duly double checked by a team of independent experts in the respective departments.

Data analyses {#s2g}
-------------

Descriptive analyses were done to understand the overall distribution (mean/proportion and corresponding 95% confidence intervals (CI)) of the patient characteristics along with drug resistance patterns. Further, stratified distributions of these characteristics across the strata of drug resistance were examined. Bivariate and multivariate logistic regression analyses \[odds ratio (OR), adjusted odds ratio (AOR) and corresponding 95%CIs\] were next conducted, respectively, to determine crude (OR) and adjusted (AOR: each predictor adjusted for all others) association between study variables. As the dependent variables (patient types, X-ray features and drug resistance patterns) had more than two categories, multinomial logistic regressions were used. [@pone.0109563-Kwak1] All statistical analyses were conducted using SAS version 9.3.

Results {#s3}
=======

Among the sputum samples collected from 458 recruited PTB cases, 35 (7.6%) got contaminated and 34 (7.4%) showed no growth. Biochemical tests and multiplex-PCR of the remaining 389 culture-positive isolates identified 350 samples positive for *M. tuberculosis* while rest 39 belonged to different Mycobacterium species. ([Figure 1](#pone-0109563-g001){ref-type="fig"}).

![Flow chart depicting the process of recruitment of the study participants.](pone.0109563.g001){#pone-0109563-g001}

Thus, altogether 350 PTB cases having *M. tuberculosis* positive sputum were included in the final analyses. Majority of them were male (71.43%), aged between 20--45 years (72.29%), married (78.57%), from low-income group (86.57%) and residents of Kolkata (80.29%). Mean BMI of the subjects was 19.24 kg/m^2^ and mean blood hemoglobin level was 10.68 gm/dl. While 31.43% (95%CI: 26.54--36.32) of the TB cases were newly diagnosed, the proportions of relapse cases, defaulters and treatment-failures were 44.00% (95%CI: 38.77--49.23), 15.43% (95%CI: 11.63--19.23) and 9.14% (95%CI: 6.11--12.18), respectively. X-Ray findings in 37.71% patients fell into the category of moderately advanced, 17.14% had far advanced X-Ray features and 9.14% had evidence of cavities. Single-positive sputum-smears were obtained from 47.14% cases, whereas double-positive and triple-positive results, respectively, were seen in 44.86% and 8.00% of patients. Among the included sputum-smear positive subjects, 12.29% (95%CI: 8.83--15.74) had MDR-TB, 57.71% (95%CI: 52.51--62.92) had non-MDR two drug resistance, while 12% (95%CI: 8.58--15.42) had resistance to any one of the first line of drugs (5.71%, 4.29% and 2.00% to only INH, Ethambutol and Rifampicin, respectively). Isolates obtained from only 18.00% (95%CI: 13.96--22.04) patients were susceptible to all three first line ATDs. ([Table 1](#pone-0109563-t001){ref-type="table"}).

10.1371/journal.pone.0109563.t001

###### Distribution of socio-demographics, patient types, physical parameters, microscopic features, X-ray findings and drug resistance patterns among PTB patients in tertiary care hospitals of Kolkata, India, 2010--2013 (N = 350).

![](pone.0109563.t001){#pone-0109563-t001-1}

  Continuous Variables                                                          n                    Mean (95% CI)      
  --------------------------------------------------------------- ------------------------------ ---------------------- -------------------------
  Body mass index (kg/m^2^)                                                    350                19.24 (19.07--19.41)  
  Blood hemoglobin level (gm/dl)                                               350                10.68 (10.52--10.85)  
  **Categorical Variables**                                               **Categories**                 **n**           **Percentage (95% CI)**
  Gender                                                                       Male                       250             71.43 (66.67--76.18)
                                                                              Female                      100             28.57 (23.82--33.33)
  Age                                                                        \<20 Yrs                      48             13.71 (10.09--17.35)
                                                                            20--45 Yrs                    253             72.29 (67.57--77.00)
                                                                             \>45 Yrs                      49             14.00 (10.35--17.65)
  Marital Status                                                             Married                      275             78.57 (74.25--82.89)
                                                                            Unmarried                      75             21.43 (17.11--25.75)
  Socio-economic status                                                        LIG                        303             86.57 (82.98--90.16)
                                                                               MIG                         45              12.86 (9.33--16.38)
                                                                               HIG                         2                0.57 (0.00--1.37)
  Resident of                                                           North 24 Parganas                  13               3.71 (1.72--5.71)
                                                                        South 24 Parganas                  56             16.00 (12.14--19.85)
                                                                             Kolkata                      281             80.29 (76.10--84.47)
  Patient type                                                            New Infection                   110             31.43 (26.54--36.32)
                                                                             Relapsed                     154             44.00 (38.77--49.23)
                                                                            Defaulter                      54             15.43 (11.63--19.23)
                                                                        Treatment failure                  32              9.14 (6.11--12.18)
  Sputum smear grade                                                          Scanty                       0                        0
                                                                         Single positive                  165             47.14 (41.89--52.40)
                                                                         Double positive                  157             44.86 (39.62--50.09)
                                                                         Triple positive                   28              8.00 (5.14--10.86)
  X Ray Findings                                                             Minimal                      126             36.00 (30.95--41.05)
                                                                       Moderately advanced                132             37.71 (32.61--42.82)
                                                                           Far advanced                    60             17.14 (13.18--21.11)
                                                                              Cavity                       32              9.14 (6.11--12.18)
  Multiple allele specific PCR for detection of drug resistance       Multi-drug resistance                43              12.29 (8.83--15.74)
                                                                   Non-MDR two drug resistance            202             57.71 (52.51--62.92)
                                                                   Only Isoniazide resistance\*            20               5.71 (3.27--8.16)
                                                                   Only Rifampicin resistance\*            15               4.29 (2.15--6.42)
                                                                   Only Ethambutol resistance\*            7                2.00 (0.53--3.47)
                                                                           Susceptible                     63             18.00 (13.96--22.04)

N = Total number of subjects in the study; n = Number of subjects in different categories.

CI = Confidence interval; LIG = Low-income group; MIG = Middle-income group; HIG = High-income group \*Total number of single drug resistant cases = 42.

Distribution of the socio-demographic characteristics along with clinical, radiological and laboratory parameters across the strata of drug resistance pattern is presented in [Table 2](#pone-0109563-t002){ref-type="table"}. Results of bivariate and multivariate (each predictor adjusted for all others) regression analyses (to determine association between patient types and their physical/socio-demographic/microscopic/X-ray features) are presented in [Table 3](#pone-0109563-t003){ref-type="table"}. Patients with higher mean BMI had lower odds (reference: new infection) of being a relapse \[AOR = 0.06(0.03--0.11)\]/defaulter \[AOR = 0.45(0.28--0.74)\]/treatment failure \[AOR = \<0.01(\<0.01--0.01)\] TB case; while those with higher hemoglobin levels had twice the odds (compared to being a new infection) of belonging to relapse \[AOR = 1.94(1.22--3.07)\] or defaulter \[AOR = 4.00(2.55--6.26)\] category. Female PTB cases, as against males, had 2.6 times higher odds of being a defaulter \[AOR = 3.66(1.33--10.06)\] than being a new infection case. Older age groups, compared to those aged \<20 years, had significantly higher odds \[20--45 years: AOR = 10.44(1.69--64.46) and \>45 years: AOR = 8.95(1.05--76.41)\] of having relapse than having new infection. Patients with worse categories of sputum positivity (vs. single positive sputum) and poorer X-ray features (vs. minimal advanced) were detected to have increased odds of having relapse/treatment-failure, although the associations did not reach levels of statistical significance, possibly due to lack of power. ([Table 3](#pone-0109563-t003){ref-type="table"}).

10.1371/journal.pone.0109563.t002

###### Distribution of drug resistance patterns across the strata of socio-demographics, patient type, X-ray features and microscopic findings among PTB patients in tertiary care hospitals of Kolkata, India, 2010--2013 (N = 350).
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                                        Susceptible        Single drug resistance      Non-MDR two drug resistance     Multi-drug resistance (MDR)                                                                                                  
  -------------------------------- --------------------- --------------------------- -------------------------------- ----------------------------- ------------------------- --------------------- ------------------------- --------------------- -------------------------
  Body mass index (kg/m^2^)                 63               19.99(19.63--20.35)                    42                     19.74(19.25--20.22)                 202             18.99(18.78--19.20)             43              18.87(18.37--19.36)  
  Blood hemoglobin level (gm/dl)            63               10.40(9.98--10.81)                     42                     10.43(9.89--10.97)                  202             10.85(10.64--11.06)             43              10.58(10.12--11.05)  
  **Categorical variables**           **Susceptible**     **Single drug resistant**   **Non-MDR two drug resistant**             **MDR**                                                                                                            
  **Variables**                       **Categories**                **n**                **Percentage (95% CI)**                  **n**              **Percentage (95% CI)**          **n**          **Percentage (95% CI)**          **n**          **Percentage (95% CI)**
  Gender                                   Male                      44                    69.84(58.19--81.49)                     31                  73.81(59.94--87.68)             143             70.80(64.47--77.12)             32              74.42(60.83--88.01)
                                          Female                     19                    30.16(18.51--41.81)                     11                  26.19(12.32--40.06)             59              29.21(22.88--35.53)             11              25.58(11.99--39.16)
  Age                                    \<20 Yrs                    15                    23.81(12.99--34.62)                      6                  14.29(3.25--25.32)              23               11.39(6.97--15.8)               4               9.30(0.26--18.35)
                                        20--45 Yrs                   44                    69.84(58.19--81.49)                     28                  66.67(51.80--81.53)             150             74.26(68.18--80.34)             31              72.09(58.12--86.06)
                                         \>45 Yrs                     4                     6.35(0.15--12.54)                       8                  19.05(6.66--31.43)              29              14.36(9.48--19.23)               8              18.60(6.49--30.72)
  Marital Status                          Married                    45                    71.43(59.96--82.90)                     33                  78.57(65.63--91.51)             162             80.20(74.66--85.74)             35              81.40(69.28--93.51)
                                         Unmarried                   18                    28.57(17.10--40.04)                      9                  21.43(8.49--34.37)              40              19.80(14.26--25.34)              8              18.60(6.49--30.72)
  Socio-economic status                     LIG                      52                    82.54(72.90--92.18)                     35                  83.33(71.58--95.09)             179             88.61(84.20--93.03)             37              86.05(75.26--96.84)
                                            MIG                      11                     17.46(7.82--27.09)                      6                  14.29(3.25--25.32)              22              10.89(6.56--15.22)               6              13.95(3.16--24.74)
                                            HIG                      --                             --                              1                    2.381(0--7.19)                 1                 0.50(0--1.47)                --                      --
  Resident of                        North 24 Parganas                2                      3.17(0.00--7.63)                       4                   9.52(0.27--18.78)               7               3.47(0.92--6.00)               --                      --
                                     South 24 Parganas                5                     7.94(1.07--14.80)                       9                  21.43(8.49--34.37)              37              18.32(12.93--23.70)              5              11.63(1.65--21.61)
                                          Kolkata                    56                    88.89(80.91--96.87)                     29                  69.05(54.47--83.63)             158             78.22(72.48--83.96)             38              88.37(78.39--98.35)
  Patient type                         New Infection                 44                    69.84(58.19--81.49)                     23                  54.76(39.06--70.46)             36              17.82(12.50--23.14)              7              16.28(4.78--27.78)
                                         Relapsed                    13                    20.63(10.36--30.91)                     15                  35.71(20.60--50.83)             106             52.48(45.53--59.42)             20              46.51(30.98--62.04)
                                         Defaulter                    5                     7.94(1.07--14.80)                       3                    7.14(0--15.27)                38              18.81(13.38--24.25)              8              18.60(6.49--30.72)
                                     Treatment failure                1                      1.59(0.00--4.76)                       1                     2.38(0--7.19)                22              10.89(6.56--15.22)               8              18.60(6.49--30.72)
  Sputum smear grade                      Scanty                      0                             0                               0                           0                       0                       0                       0                       0
                                      Single positive                34                    53.97(41.31--66.62)                     12                  28.57(14.32--42.82)             99              49.00(42.06--55.96)             20              46.51(30.98--62.04)
                                      Double positive                27                    42.86(30.29--55.42)                     28                  66.67(51.80--81.53)             81              40.10(33.28--46.91)             21              48.84(33.27--64.40)
                                      Triple positive                 2                       3.17(0--7.63)                         2                    4.76(0--11.48)                22              10.89(6.56--15.22)               2                4.65(0--11.21)
  X- Ray Findings                         Minimal                    21                    33.33(21.37--45.30)                     11                  26.19(12.32--40.06)             76              37.62(30.89--44.36)             18              41.86(26.50--57.22)
                                    Moderately advanced              27                    42.86(30.30--55.42)                     18                  42.86(27.25--58.47)             74              36.63(29.93--43.33)             13              30.23(15.93--44.53)
                                       Far advanced                  12                     19.05(9.08--29.02)                      9                  21.43(8.49--34.37)              29              14.36(9.48--19.23)              10              23.26(10.10--36.41)
                                          Cavity                      3                       4.76(0--10.17)                        4                   9.52(0.27--18.78)              23              11.39(6.97--15.80)               2                4.65(0--11.21)

N = Total number of subjects in the study; n = Number of subjects in different categories.

CI = Confidence interval; LIG = Low-income group; MIG = Middle-income group; HIG = High-income group.

10.1371/journal.pone.0109563.t003

###### Association between patient type and their physical, socio-demographic, microscopic and X-ray features among PTB patients in tertiary care hospitals of Kolkata, India, 2010--2013 (N = 350).

![](pone.0109563.t003){#pone-0109563-t003-3}

                                                 Patient type(ref: New infection)                                                                                                                                                     
  --------------------------------------------- ---------------------------------- ---------------------- ----------------------- ---------------------- ----------------------- -------------------------- ------------------------- -----------
  Body mass index (kg/m^2^)                                    UOR                    0.06(0.04--0.11)            \<.001             0.44(0.30--0.66)            \<.001             \<0.01(\<0.01--0.01)             \<.001           
                                                               AOR                  **0.06(0.03--0.11)**        **\<.001**         **0.45(0.28--0.74)**         **0.002**         **\<0.01(\<0.01--0.01)**         **\<.001**         
  Blood hemoglobin level (gm/dl)                               UOR                    2.58(1.98--3.35)            \<.001             3.33(2.32--4.79)            \<.001               1.47(1.03--2.10)                0.035           
                                                               AOR                  **1.94(1.22--3.07)**         **0.005**         **4.00(2.55--6.26)**        **\<.001**             0.67(0.29--1.57)                0.354           
  **Categorical variables**                                **Relapsed**                **Defaulter**              **TF**                                                                                                              
  **Variables**                                           **Categories**               **OR(95%Cl)**              ***p***             **OR(95%Cl)**              ***p***               **OR(95%Cl)**                 ***p***          
  Gender (ref: male)                                          Female                        UOR              0.71(0.41--1.24)             0.228             1.27(0.63--2.53)               0.503                1.40(0.61--3.19)         0.423
                                                                                            AOR              1.18(0.38--3.61)             0.779           **3.66(1.33--10.06)**          **0.012**              1.70(0.32--9.01)         0.535
  Age (ref:\<20 yrs)                                        20--45 yrs                      UOR              2.50(1.21--5.16)             0.013             1.57(0.65--3.83)               0.319                2.35(0.65--8.55)         0.194
                                                                                            AOR            **10.44(1.6964.46)**         **0.012**           2.80(0.59--13.32)              0.195              65.61(2.78--\>99.99)       0.010
                                                             \>45 yrs                       UOR              3.56(1.37--9.24)             0.009             1.20(0.32--4.47)               0.788                3.83(0.81--18.09)        0.090
                                                                                            AOR            **8.95(1.05--76.41)**        **0.045**           1.76(0.25--12.71)              0.574              77.02(1.90--\>99.99)       0.022
  Marital status (ref: Married)                             Unmarried                       UOR              0.33(0.18--0.60)             0.001             0.40(0.17--0.89)               0.026                0.55(0.22--1.40)         0.210
                                                                                            AOR              0.99(0.19--5.21)             0.990             0.58(0.14--2.45)               0.455                5.27(0.36--76.93)        0.224
  SES (ref: LIG)                                               MIG                          UOR              0.52(0.24--1.09)             0.081             0.89(0.36--2.19)               0.799                0.98(0.33--2.90)         0.975
                                                                                            AOR              0.46(0.13--1.72)             0.251             0.69(0.23--2.10)               0.515                1.57(0.19--12.99)        0.678
                                                               HIG                          UOR                     --                      --                     --                        --                        --                 --
                                                                                            AOR                     --                      --                     --                        --                        --                 --
  Resident of (ref: Kolkata)                            North 24 Parganas                   UOR              0.23(0.05--1.19)             0.079             1.35(0.36--5.03)               0.656                0.54(0.06--4.66)         0.573
                                                                                            AOR              0.14(0.01--2.19)             0.160             1.55(0.31--7.76)               0.593                0.05(0.01--2.60)         0.139
                                                        South 24 Parganas                   UOR              1.16(0.60--2.24)             0.669             0.83(0.32--2.16)               0.707                0.76(0.24--2.45)         0.643
                                                                                            AOR              0.88(0.25--3.08)             0.846             0.55(0.15--1.10)               0.366                0.22(0.03--1.90)         0.170
  Sputum smear grading (ref: Single positive)            Double positive                    UOR              2.55(1.52--4.29)             0.001             1.07(0.54--2.14)               0.840               11.81(3.28--42.53)        0.001
                                                                                            AOR              1.48(0.47--4.73)             0.505             1.01(0.35--2.90)               0.988                2.23(0.25--19.85)        0.472
                                                         Triple positive                    UOR              3.45(1.06--11.26)            0.040             1.05(0.18--6.00)               0.960              57.49(11.18--295.51)      \<.001
                                                                                            AOR              0.84(0.07--10.56)            0.892             1.05(0.06--17.33)              0.971                0.92(0.03--32.08)        0.963
  X-ray (ref: Minimal)                                 Moderately advanced                  UOR              1.69(1.00--2.95)             0.065             1.67(0.82--3.38)               0.157             **12.60(1.54--103.43)**   **0.018**
                                                                                            AOR              1.15(0.38--3.49)             0.806             1.99(0.78--5.07)               0.152                1.64(0.11--24.83)        0.722
                                                           Far advanced                     UOR              2.86(1.29--6.37)             0.010             1.69(0.58--4.96)               0.334               76.35(9.12--639.18)      \<.001
                                                                                            AOR              1.95(0.32--11.91)            0.468             1.66(0.30--9.24)               0.563               9.77(0.44--217.99)        0.150
                                                              Cavity                        UOR              8.17(2.29--29.07)            0.001             0.89(0.09--9.03)               0.921              130.65(1.91--\>99.99)     \<.001
                                                                                            AOR              4.54(0.41--50.66)            0.220             0.55(0.02--13.24)              0.713              33.93(0.84--\>99.99)       0.062

N = Total number of subjects in the study; SES = Socio-economic status; LIG = Low-income group; MIG = Middle-income group; HIG = High-income group; UOR = Unadjusted Odds ratio; AOR = Adjusted Odds ratio; OR = Odds ratio; CI = Confidence interval; *p* = *p* value.

"--" refers to cells for which due to inadequate number of observation valid statistical results (OR, CI, *p* value) could not be determined.

Patients with higher mean BMI had lower odds of having poorer X-ray features \[AOR for: moderately advanced = 0.71(0.55--0.91) and far advanced = 0.69(0.49--0.98)\], whereas cases diagnosed with double-positive sputum-smear (vs. single-positive sputum) were more likely to have the same \[AOR for: moderately advanced = 3.40(1.88--6.14) and far advanced = 88.95(19.72--401.20)\], compared to having minimal advanced X-ray features. Female \[AOR = 2.28(1.18--4.41, reference: male)\], elderly \[AOR = 4.13(1.02--16.68, reference: age \<20 years)\] and unmarried \[AOR = 4.39(1.63--11.86, reference: married)\] cases were also found to have higher odds of moderately advanced (compared to minimal advanced) X-ray features. ([Table 4](#pone-0109563-t004){ref-type="table"}).

10.1371/journal.pone.0109563.t004

###### Association of X-ray findings with physical, socio-demographic and microscopic features among PTB patients in tertiary care hospitals of Kolkata, India, 2010--2013 (N = 350).
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                                                 X-Ray findings (ref: Minimal)                                                                                                                                                
  --------------------------------------------- ------------------------------- ---------------------- ----------------------- ---------------------- -------------------------- ------------------ ------------------------- -----------
  Body mass index (kg/m^2^)                                   UOR                  0.71(0.57--0.87)             0.001             0.53(0.40--0.70)             \<.0001            0.42(0.29--0.63)           \<.0001          
                                                              AOR                **0.71(0.55--0.91)**         **0.006**         **0.69(0.49--0.98)**          **0.036**           0.64(0.38--1.05)            0.078           
  Blood hemoglobin level (gm/dl)                              UOR                  0.97(0.79--1.19)             0.757             0.96(0.74--1.24)              0.737             1.31(0.93--1.86)            0.119           
                                                              AOR                  1.01(0.78--1.31)             0.926             0.89(0.62--1.28)              0.537             1.41(0.85--2.37)            0.187           
  **Categorical variables**                         **Moderately advanced**        **Far advanced**          **Cavity**                                                                                                       
  **Variables**                                         **Categories**              **OR(95%Cl)**              ***p***             **OR(95%Cl)**               ***p***             **OR(95%Cl)**             ***p***          
  Gender (ref:Male)                                         Female                       UOR              1.63(0.93--2.85)             0.085               1.88(0.96--3.71)            0.066            1.37(0.57--3.29)         0.482
                                                                                         AOR            **2.28(1.18--4.41)**         **0.015**             2.37(0.93--6.04)            0.071            2.96(0.86--10.23)        0.087
  Age (ref:\<20 yr)                                        20--45 yr                     UOR              0.92(0.45--1.90)             0.832               0.60(0.26--1.38)            0.232            3.89(0.49--30.85)        0.198
                                                                                         AOR              2.53(0.80--7.98)             0.113               0.56(0.11--2.87)            0.483            0.67(0.03--15.22)        0.800
                                                            \>45 yr                      UOR              1.45(0.55--3.80)             0.447               0.76(0.23--2.48)            0.653         **11.77(1.32--104.99)**   **0.027**
                                                                                         AOR            **4.13(1.02--16.68)**        **0.047**             0.66(0.09--4.92)            0.685            1.71(0.06--48.71)        0.752
  Marital status (ref: Married)                            Unmarried                     UOR              1.84(1.01--3.34)             0.045               1.58(0.75--3.31)            0.231            0.15(0.02--1.18)         0.071
                                                                                         AOR            **4.39(1.63--11.86)**        **0.004**             1.16(0.26--5.10)            0.845            0.12(0.01--2.43)         0.166
  SES (ref:LIG)                                               MIG                        UOR              1.25(0.59--2.64)             0.555               1.05(0.40--2.75)            0.925            1.90(0.67--5.44)         0.230
                                                                                         AOR              1.12(0.48--2.63)             0.786               1.01(0.31--3.33)            0.982            2.27(0.53--9.80)         0.271
                                                              HIG                        UOR                     --                      --                       --                     --             4.44(0.27--73.42)        0.298
                                                                                         AOR                     --                      --                       --                     --                    --                 --
  Resident of (ref: Kolkata)                           North 24 Parganas                 UOR              2.04(0.60--6.98)             0.257               0.53(0.06--4.87)            0.575                   --                 --
                                                                                         AOR              1.85(0.47--7.27)             0.375               0.33(0.03--3.65)            0.365                   --                 --
                                                       South 24 Parganas                 UOR              1.25(0.63--2.46)             0.526               1.18(0.51--2.74)            0.702            1.33(0.48--3.69)         0.580
                                                                                         AOR              0.98(0.46--2.08)             0.952               0.81(0.28--2.31)            0.695            1.45(0.40--5.26)         0.574
  Sputum smear grading (ref: Single positive)           Double positive                  UOR              3.97(2.28--6.90)            \<.0001            92.31(21.04--405.03)         \<.0001                  --                 --
                                                                                         AOR            **3.40(1.88--6.14)**        **\<.0001**        **88.95(19.72--401.20)**     **\<.0001**                --                 --
                                                        Triple positive                  UOR                     --                      --                       --                     --                    --                 --
                                                                                         AOR                     --                      --                       --                     --                    --                 --

SES = Socio-economic status; LIG = Low-income group; MIG = Middle-income group; HIG = High- income group; UOR = Unadjusted Odds ratio; AOR = Adjusted Odds ratio; OR = Odds ratio; CI = Confidence interval; *p* = *p* value.

"--" refers to cells for which due to inadequate number of observation valid statistical results (OR, CI, *p* value) could not be determined.

Cases belonging to older age groups, as against those aged \<20 years, had higher odds of having MDR (AOR~MDR~) and non-MDR two drug resistant TB (AOR~NM2DR~) than having a TB strain susceptible to all three first-line drugs \[for 20--45 years age-group: AOR~MDR~ = 7.30(1.10--48.59) and AOR~NM2DR~ = 4.59(1.16--18.12) while for \>45 years, AOR~MDR~ = 30.01(2.70--333.06) and AOR~NM2DR~ = 12.14(1.82--80.92)\]. Unmarried cases (vs. married) had more than four times odds of being diagnosed with either AOR~MDR~ or AOR~NM2DR~, compared to being in the all susceptible group \[AOR~MDR~ = 4.83(1.10--48.59) and AOR~NM2DR~ = 4.59(0.99--23.66)\]. Higher odds of AOR~MDR~ and AOR~NM2DR~ were also observed for relapse/defaulter/treatment-failure groups, as compared to new infection cases \[relapse: AOR~MDR~ = 13.84(2.55--75.06) and AOR~NM2DR~ = 12.02(3.51--41.15); defaulter: AOR~MDR~ = 33.01(5.96--182.78) and AOR~NM2DR~ = 16.87(4.77--59.69); treatment-failure: AOR~MDR~ = 63.19(3.63--\>99.99) and AOR~NM2DR~ = 31.86(2.66--381.62)\], whereas patients with moderately/far advanced X-ray findings (vs. minimal advanced) were less likely to be suffering from either AOR~MDR~ or AOR~NM2DR~ \[moderately advanced: AOR~MDR~ = 0.16(0.05--0.53) and AOR~NM2DR~ = 0.27(0.11--0.67); far advanced: AOR~MDR~ = 0.14(0.03--0.68) and AOR~NM2DR~ = 0.14(0.04--0.49)\]. ([Table 5](#pone-0109563-t005){ref-type="table"}).

10.1371/journal.pone.0109563.t005

###### Association between patient characteristics and drug resistance patterns among PTB patients in tertiary care hospitals of Kolkata, India, 2010--2013 (N = 350).
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                                                 Drug resistant status (ref:Susceptible)                                                                                                                                                                 
  --------------------------------------------- ----------------------------------------- --------------------------------- --------------------------------- ------------------ ------------------------- ------------------ -------------------------- -------------
  Body mass index (kg/m^2^)                                        UOR                            0.83(0.59--1.16)                        0.279                0.49(0.38--0.63)           \<.0001           0.44(0.31--0.63)           \<.0001           
                                                                   AOR                            1.18(0.66--2.13)                        0.572                0.73(0.46--1.15)            0.171            0.62(0.34--1.15)            0.130            
  Blood hemoglobin level (gm/dl)                                   UOR                            1.02(0.74--1.41)                        0.896                1.38(1.08--1.75)            0.009            1.14(0.82--1.57)            0.435            
                                                                   AOR                            0.92(0.61--1.39)                        0.685                1.00(0.71--1.41)            0.994            0.71(0.45--1.13)            0.148            
  **Categorical variables**                            **Single drug resistance**          **Non-MDR two drug resistance**   **Multi-drug resistance (MDR)**                                                                                             
  **Variables**                                              **Categories**                         **OR(95%Cl)**                        ***p***                **OR(95%Cl)**             ***p***            **OR(95%Cl)**             ***p***           
  Gender (ref: Male)                                             Female                                  UOR                        0.82(0.34--1.97)                0.660            0.95(0.51--1.77)            0.885             0.80(0.33--1.90)          0.608
                                                                                                         AOR                        1.02(0.37--2.86)                0.965            1.43(0.63--3.27)            0.391             1.01(0.35--2.96)          0.981
  Age(ref:\<20 yr)                                              20--45 yr                                UOR                        1.59(0.55--4.59)                0.390            2.22(1.07--4.62)            0.032             2.64(0.80--8.77)          0.111
                                                                                                         AOR                        1.64(0.30--8.86)                0.563          **4.59(1.16--18.12)**       **0.030**        **7.30(1.10--48.59)**      **0.040**
                                                                 \>45 yr                                 UOR                        5.00(1.08--23.06)               0.039            4.73(1.38--16.19)           0.013            7.45(1.47--38.27)          0.015
                                                                                                         AOR                        5.69(0.64--50.65)               0.119         **12.14(1.82--80.92)**       **0.010**       **30.01(2.70--333.06)**     **0.006**
  Marital status (ref: Married)                                 Unmarried                                UOR                        0.68(0.27--1.71)                0.413            0.62(0.32--1.18)            0.144             0.57(0.22--1.47)          0.244
                                                                                                         AOR                        1.71(0.38--7.67)                0.483          **4.16(1.20--14.48)**       **0.025**          4.83(0.99--23.66)          0.052
  SES (ref: LIG)                                                   MIG                                   UOR                        0.81(0.27--2.39)                0.704            0.58(0.26--1.28)            0.176             0.77(0.26--2.26)          0.630
                                                                                                         AOR                        0.47(0.13--1.67)                0.243            0.64(0.24--1.73)            0.382             0.92(0.25--3.35)          0.904
                                                                   HIG                                   UOR                               --                         --                    --                     --                     --                  --
                                                                                                         AOR                               --                         --                    --                     --                     --                  --
  Resident of (ref: Kolkata)                                North 24 Parganas                            UOR                        3.86(0.67--22.35)               0.131            1.24(0.25--6.15)            0.792                    --                  --
                                                                                                         AOR                        5.37(0.69--41.42)               0.107            2.46(0.30--20.49)           0.405                    --                  --
                                                            South 24 Parganas                            UOR                        3.48(1.07--11.33)               0.039            2.62(0.98--7.00)            0.054             1.47(0.4--5.44)           0.561
                                                                                                         AOR                      **3.61(1.03--12.63)**           **0.044**        **3.54(1.14--10.91)**       **0.028**           1.93(0.45--8.16)          0.374
  Sputum smear grading (ref: Single positive)                Double positive                             UOR                        2.94(1.26--6.83)                0.012            1.03(0.57--1.85)            0.920             1.32(0.60--2.92)          0.491
                                                                                                         AOR                        2.52(0.87--7.35)                0.089            0.65(0.27--1.56)            0.338             0.90(0.29--2.83)          0.858
                                                             Triple positive                             UOR                        2.83(0.36--22.39)               0.324            3.78(0.84--16.91)           0.082            1.70(0.22--13.02)          0.610
                                                                                                         AOR                        2.10(0.18--25.19)               0.557            2.41(0.34--16.99)           0.377            0.85(0.06--11.27)          0.904
  X-ray(ref: Minimal)                                      Moderately advanced                           UOR                        1.27(0.50--3.27)                0.616            0.76(0.39--1.46)            0.405             0.56(0.22--1.40)          0.216
                                                                                                         AOR                        0.83(0.27--2.51)                0.738          **0.27(0.11--0.67)**        **0.004**         **0.16(0.05--0.53)**      **0.003**
                                                              Far advanced                               UOR                        1.43(0.46--4.44)                0.534            0.67(0.29--1.53)            0.339             0.97(0.34--2.78)          0.958
                                                                                                         AOR                        0.58(0.14--2.44)                0.455          **0.14(0.04--0.49)**        **0.002**         **0.14(0.03--0.68)**      **0.015**
                                                                 Cavity                                  UOR                        2.54(0.48--13.46)               0.272            2.12(0.58--7.75)            0.257             0.78(0.12--5.18)          0.795
                                                                                                         AOR                        0.78(0.11--5.96)                0.827            0.29(0.05--1.64)            0.161             0.11(0.01--1.17)          0.067
  Patient type (ref: New Infection)                             Relapsed                                 UOR                        2.20(0.90--5.42)                0.084            9.97(4.83--20.58)          \<.0001           9.67(3.35--27.91)         \<.0001
                                                                                                         AOR                        3.01(0.62--15.35)               0.168         **12.02(3.51--41.15)**      **\<.0001**       **13.84(2.55--75.06)**     **0.002**
                                                                Defaulter                                UOR                        1.15(0.25--5.24)                0.859            9.23(3.31--26.05)          \<.0001           10.06(2.55--39.69)         0.001
                                                                                                         AOR                        1.79(0.31--10.18)             **0.510**       **16.87(4.77--59.69)**      **\<.0001**      **33.01(5.96--182.78)**    **\<.0001**
                                                            Treatment failure                            UOR                        1.91(0.11--32.00)               0.652           26.88(3.45--209.19)          0.002           50.28(5.42--465.91)         0.001
                                                                                                         AOR                        1.67(0.05--59.93)               0.780         **31.86(2.66--381.62)**      **0.006**       **63.19(3.63--\>99.99)**    **0.005**

SES = Socio-economic status; LIG = Low-income group; MIG = Middle-income group; HIG = High-income group; UOR = Unadjusted Odds ratio; AOR = Adjusted Odds ratio; OR = Odds ratio; CI = Confidence interval; *p* = *p* value.

"--" refers to cells for which due to inadequate number of observation valid statistical results (OR, CI, *p* value) could not be determined

Discussion {#s4}
==========

Among 350 adolescent and adult smear-confirmed PTB patients due to M. tuberculosis infection, who attended two tertiary care hospitals in Kolkata between 2010--13, 68.57% belonged to relapse (44.00%), defaulter (15.43%) or treatment-failure (9.14%) categories, 64.00% had poorer X-ray features (moderately advanced = 37.71%, far advanced = 17.14% and cavities = 9.14%) and 12.29% were diagnosed with MDR-PTB. MDR-TB consisted 6.36% of total new infections cases, but 15% among the previously treated group. These findings probably serve as a grim reminder of the prevailing complex scenario of PTB in the largest metropolitan city of eastern India, which is not unlike rest of the country. [@pone.0109563-Maurya1], [@pone.0109563-Sharma2], [@pone.0109563-Sharma3] It is worth noting that the burden of MDR-PTB among newly infected [@pone.0109563-Sharma3] and previously treated cases [@pone.0109563-Sharma2] in most Indian states have consistently remained high during past two decades, and even more alarmingly, a recent report suggested a gradually increasing trend in MDR-PTB prevalence across the country. [@pone.0109563-Maurya1] In view of the above, our study findings convey that Kolkata is no exception.

In this study, corroborating with prior researches, having higher BMI was negatively associated with being a relapse/defaulter/treatment-failure case. [@pone.0109563-Dooley1], [@pone.0109563-Khan1] Improved nutritional status, which can positively influence immunity and treatment outcome, could be cited as a possible explanation; however, such finding could also have been an artifact of reverse causation, as implicated by deterioration of general health among relapse/defaulter/treatment-failure cases. We believe, our results indicate the importance of providing nutritional improvement counseling/advices during the course of TB treatment.

Relapsed cases and defaulters were found to have, counter-intuitively, higher hemoglobin level. However, this again might be explained by possible reverse causation resulting from discontinuation of ATD therapy following initial physiological improvement (thus increase in hemoglobin) with the therapy. Thus, proper adherence counseling of patients at the time of initiating ATD is profoundly recommended.

Female subjects, in our study, were more likely to default in treatment compared to males, contradicting findings from previous studies, conducted elsewhere. [@pone.0109563-Dooley1], [@pone.0109563-Santha1], [@pone.0109563-Jha1] We hypothesize that the socio-cultural norms prevailing in the study area might have led to either lower awareness/adherence regarding ATD among females or had resulted in an underrepresentation of females among attendees of tertiary healthcare centers with uncomplicated, new infections.

Higher age was associated positively with relapse, potentially owing to poorer treatment outcomes resulting from different biological (diminishing immune function with increasing age) and social issues (self-neglect and poor knowledge/perception among elderly populace) working independently or in tandem. [@pone.0109563-Zaveri1].

Although the employed multivariate model lacked sufficient statistical power, results of bivariate analyses suggested that poorer prognostic categories of sputum-smear and chest radiographic features were both associated with higher likelihood of being a relapse/treatment-failure case. Taking into account tubercular disease pathogenesis, these findings seem inherently plausible. In the current study, compared to the corresponding reference groups, females, elderly, unmarried and worse grades of sputum-smear were positively associated with poorer/more advanced chest-X-ray features, but higher BMI appeared to be a negative correlate of the same. Based on above, it is suggested that these socio-demographic and clinical parameters might well be taken into account while planning, designing and implementing preventive and curative components of the TB control program in this part of the country.

In this study higher age was found to be associated with higher odds of being MDR or non-MDR 2 drug resistant PTB cases, which highlighted the crucial role of poor awareness/perception, healthcare access/utilization and relatively lower social attention towards the elderly populace. [@pone.0109563-Zaveri1].

Unmarried subjects also appeared to be more likely to be suffering from MDR or non-MDR 2 drug resistant PTB, compared to their married counterparts, and behavioral factors might be implicated behind this association. [@pone.0109563-Young1].

In sync with our observation regarding treatment outcomes, higher BMI seemed to be also associated negatively with emergence of drug resistance among participating PTB cases.

In corroboration with prior findings, relapse/defaulters/treatment-failure cases were found to have higher propensity of being MDR and non-MDR 2 drug resistant cases of PTB. [@pone.0109563-Weyer1], [@pone.0109563-Banu1], [@pone.0109563-Lomtadze1].

Interestingly, it was observed that subjects with advanced radiological features had lower odds of having MDR or non-MDR 2 drug resistant PTB. Such observation points towards the possibility that cases with advanced radiological findings might be more likely to have been subjected to aggressive therapeutic and behavioral (counseling) interventions, often leading to improved treatment response and adherence, and therefore, lower likelihood of development of resistance.

Overall, the findings regarding resistance pattern seen in our study participants, make us infer that appropriate and intensive counseling of ATD initiates should be emphasized upon, in order to improve adherence to the treatment protocol among the PTB cases, and thereby reduce emergence of resistance.

Our study suffered from some major limitations. Due to the cross-sectional design, causal interpretations of the observed associations were not possible and temporal ambiguity affected inferences due to the potential for reverse causation. As the study was conducted in two tertiary care hospitals of Kolkata, often receiving referred (and relatively severe) cases from lower level healthcare providers, we might have overestimated the overall burden and some severity characteristics. Hence, extrapolation of the results beyond the study sample is not recommended, as lack of external validity may be suspected.

Despite of these limitations, we believe, our study findings have been bolstered by employing advanced laboratory techniques like MAS-PCR and sophisticated statistical analyses. The results of this study may help concerned policy makers to gain important insights into the aspects and correlates of drug resistance and treatment outcomes of PTB cases in this part of India, where similar efforts have been scanty till date.

Conclusions {#s5}
===========

Implementation of targeted intervention and appropriate counseling seem to be an urgent requirement in order to improve the efficacy of various TB control approaches for specific demographics like females, elderly and unmarried in Kolkata.
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